The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.
about
Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cellsHuman prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasterideTargeting cancer using cholesterol conjugatesAndrogen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cellsAge-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progressionCirculating dihydrotestosterone may not reflect peripheral formationUnexpected virilization in male mice lacking steroid 5 alpha-reductase enzymesEfficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year StudyConcentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dogTransient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late lifeFinasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention TrialAndrogen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathwaysExpression of 5α- and 5β-reductase in spinal cord and muscle of birds with different courtship repertoires.Biosynthesis of catalytically active rat testosterone 5 alpha-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA.Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors.Progesterone "receptors" in the cytoplasm and nucleus of chick oviduct target tissueMale hypogonadism.Improving intermittent androgen deprivation therapy: lessons learned from basic and translational researchProstate cancer: 9. Treatment of advanced disease.The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols.Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization.Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats.3Alpha-androstanediol kinetics in man.Androgen and its receptor promote Bax-mediated apoptosisFeed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductaseMolecular Basis of Steroid Action in the Prostate.9S binding protein for androgens and progesterone.Selected biochemical actions of ovarian hormonesThe conversion of testosterone to 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man.The source of plasma dihydrotestosterone in man.Studies on testosterone metabolism in subjects with testicular feminization syndrome.Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.Hormonal influences in breast cancer.Androgen receptor: structure, role in prostate cancer and drug discovery.An update on androgen deprivation therapy for prostate cancer.Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesisIntersex disorders in the newborn. A brief summary of current views.5α-Reductase Isozymes in the ProstateCloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone
P2860
Q24314557-5C5F4142-615F-4EC8-A460-C0E77A22F6EBQ24603802-99574E55-1BE1-40CD-BC77-7010C8FD4B63Q26860103-C96768DD-33FA-4BED-9A57-92AD7A6A7431Q27013914-03284F05-E263-4637-BC23-A3E3D85B4135Q27027373-FDF6AEC0-C8AC-4141-837A-3D1981C9E3F0Q28361810-2907C74E-B96D-453F-8F2D-53B60EC6DF5EQ28362109-08F55F41-FB12-495F-A29D-28F692278865Q28379286-DDCB7A20-89A4-4702-9B49-6269544E8D6DQ28386165-FB488DFB-EA13-49CC-BF81-EA5298FC16F3Q28505915-759F0E39-335A-4302-AA26-7EA7279BFA65Q28547130-93DAA89D-6881-4372-902A-839371C00499Q28564384-948C2672-7DB9-4704-90F3-EC9A37E3B65EQ30381562-C54B21E6-07A2-42A8-A155-028A1080C2F9Q33638390-763201FE-A5F0-47B7-A199-A7FFCEB7C7C6Q33651363-A8769613-1097-4271-AA24-A47CDA2986E9Q33704475-1B18CD69-4562-4B0E-9B32-3BDB16C9D96BQ33824078-E790335A-A5E5-4DC1-8B43-E6D249AA2341Q33922371-5B5ECC49-63B3-4D5D-B178-6CE56EC2C5D1Q34030515-A9FA1B05-B302-45C8-ABD0-0500FBD496E0Q34062274-FFFBFDA3-8422-4658-BB10-63984E1D71A4Q34064040-6C7B02B6-EC87-4D63-A186-9969E8E2BD71Q34071470-FD8A7E03-A14A-4339-A92B-85AAEA958932Q34398055-75BB4704-41A6-4B37-9A90-484CE8A596DCQ34466624-7560434C-D0B3-4C29-BB9C-70AA08E3DBA1Q34519663-C7B5C069-C6AF-427C-BC71-526F6245E02DQ34565758-18883EAD-EACD-4511-9EDD-D74C6A55644BQ35024939-10A62C3A-D972-4978-9A2D-C000A0C659BFQ35026825-D26ED47B-B2FA-415B-A1C7-CE179CFB7591Q35035190-DA1CDD1E-2019-4FFD-ACAB-EA2AE402A5AEQ35568001-09771FFC-5915-4111-9279-2DBAE340B0C4Q35571941-51E2B8AA-F4E6-4A27-A845-7E645FA8C91EQ35573898-65B216B2-F195-4650-863D-B114AFCAFC56Q35580104-92D32975-CA41-4CFF-A5D6-C5216D59B626Q35667492-18AE8461-9B2F-479C-9A48-DEA9F6636F4DQ36063723-7D0473DD-40A6-4C32-BC9D-DD941C8BFADDQ36289952-0CE29E84-901C-4736-8B06-F9C14FAB5850Q36641822-ADE44DBA-4948-44F7-9C1F-5E7838C08D57Q36659817-4D08E449-2C56-4EA1-B463-1820F1442854Q36661343-172ED50E-F8CE-439C-A373-655B65243EAAQ36763932-8CC2E712-B4D5-4DA6-84A4-8BDFA41C0480
P2860
The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
The conversion of testosterone ...... prostate in vivo and in vitro.
@en
The conversion of testosterone ...... prostate in vivo and in vitro.
@nl
type
label
The conversion of testosterone ...... prostate in vivo and in vitro.
@en
The conversion of testosterone ...... prostate in vivo and in vitro.
@nl
prefLabel
The conversion of testosterone ...... prostate in vivo and in vitro.
@en
The conversion of testosterone ...... prostate in vivo and in vitro.
@nl
P1476
The conversion of testosterone ...... prostate in vivo and in vitro.
@en
P2093
Bruchovsky N
P304
P407
P577
1968-04-01T00:00:00Z